Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience.
Battisti NML, Rogerson F, Lee K, Shepherd S, Mohammed K, Turner N, McGrath S, Okines A, Parton M, Johnston S, Allen M, Ring A.
Battisti NML, et al. Among authors: ring a.
Cancer Treat Res Commun. 2020;24:100188. doi: 10.1016/j.ctarc.2020.100188. Epub 2020 Jun 27.
Cancer Treat Res Commun. 2020.
PMID: 32619830
Free article.